Prognostic analysis of Chinese patients with metastasis renal cell cancer receiving sorafenib: results from a multicenter long-term follow-up retrospective study

The effects of sorafenib for Chinese patients with metastatic renal cell cancer (mRCC) were evaluated to figure out the relationship between clinical variables and prognosis. The data were analyzed retrospectively from six comprehensive cancer centers in Northeast China. All cases were diagnosed as...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	OncoTargets and therapy 2015-01, Vol.8, p.1581-1588
Hauptverfasser:	Guo, Fang, Han, Tao, Liu, Zhaozhe, Song, Xishuang, Zhang, Qifu, Kong, Xiangbo, Li, Changfu, Li, Zhenhua, Li, Chengge, Qu, Shuxian, Zheng, Zhendong, Piao, Ying, Han, Yaling, Xie, Xiaodong
Format:	Artikel
Sprache:	eng
Schlagworte:	Drug targeting Drug therapy Innovations Kidney cancer Original Research
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!